Australia is set to introduce the LinkMyCare programme for people with chronic obstructive pulmonary disease (COPD) in South Eastern New South Wales (NSW). The programme will be implemented across ...

Smsbiotech Inc. has gained clearance in Australia to begin a phase I trial of its small mobile stem (SMS) cell therapy for chronic obstructive pulmonary disease (COPD). BioWorld Science Regulatory ...

The trial will focus on evaluating the safety and tolerability of the company's innovative Small Mobile stem (SMS) cell therapy for Chronic Obstructive Pulmonary Disease (COPD). This development marks ...

SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing approval to commence a Phase I clinical trial in Australia (registration number ...